Analyst Insights
Top Analyst Slashes Roku Stock Over Growth, China Fears
After being up more than 40%, it looks like Roku’s (ROKU) stock will end 2018 deep in the red. The smart-TV company is …
JMP Analyst Pounds the Table on Amazon (AMZN) Stock
The holiday season is fast underway, providing the perfect time to discuss Amazon (AMZN). While the tech titan has seen surging growth in …
Bausch Health (BHC) Stock: Steadfast Bear Raises a New Alarm
Is Bausch Health (BHC) making a mistake in acquiring certain assets of Synergy Pharmaceuticals (SGYP)? Maybe — at least if you ask Wells Fargo’s David Maris.
Is There Any Hope for Neurocine Biosciences (NBIX) Stock? Cowen Weighs In
Neurocine Biosciences (NBIX) stock dropped about 14% Wednesday after news that its clinical trial for Ingrezza T-Force GOLD, for the treatment of Tourrette …
This Analyst Explains Why Tesla (TSLA) Stock Has a Solid Future
Oppenheimer analyst Colin Rusch believes Tesla (TSLA) shares are “poised to break higher” as we go out of 2018 and into the new …
Another Analyst Reduces Micron (MU) Stock Price Forecast; Here’s Why
2018 is proving to be one to forget for Micron (MU). After the stock surged more than 40% between January and March, the …
Analyst Scales Back Target on Advanced Micro Device (AMD) Stock Amid Lower CPU Demand
While excitement is building for Advanced Micro Device’s (AMD) 2019 release of its new 7-nanometer processing chip and the company is rumored to …
Aphria (APHA) Analyst Drops Bomb on Stock After Short Report Scandal
Following an intense short report alleging Aphria (APHA), a Canadian cannabis company, is scamming its investors, analysts are having second guesses about the …
Bausch Health (BHC) (Tries) to Save Synergy Pharmaceuticals (SGYP) While It’s Down; Analyst Sees Upside for the Stock
Bausch Health Companies (BHC) announced today it will acquire some assets of Synergy Pharmaceuticals, which is being called the “stalking horse” agreement – …
Oracle’s (ORCL) Flat Revenue Keeps This Top Analyst Sidelined on the Stock
2018 has been a disappointing year for Oracle (ORCL) investors. While database and cloud rivals, including Amazon and Microsoft, have seen their stocks …